MXPA03010939A - Un metodo de arilacion para la funcionalizacion de derivados de eritromicina de o-alilo. - Google Patents

Un metodo de arilacion para la funcionalizacion de derivados de eritromicina de o-alilo.

Info

Publication number
MXPA03010939A
MXPA03010939A MXPA03010939A MXPA03010939A MXPA03010939A MX PA03010939 A MXPA03010939 A MX PA03010939A MX PA03010939 A MXPA03010939 A MX PA03010939A MX PA03010939 A MXPA03010939 A MX PA03010939A MX PA03010939 A MXPA03010939 A MX PA03010939A
Authority
MX
Mexico
Prior art keywords
erythromycin
heck reaction
derivative
alkenylaryl
arylation
Prior art date
Application number
MXPA03010939A
Other languages
English (en)
Inventor
R Haight Anthony
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MXPA03010939A publication Critical patent/MXPA03010939A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe una tecnica de arilacion eficiente para usarse en la sintesis de derivados de eritromicina, que envuelve una reaccion de Heck modificada, que emplea menos de seis por ciento en moles de catalizador de paladio y ninguna fosfina. Con esta reaccion de Heck modificada, se puede obtener un macrolido de O-alquenilarilo en un tiempo de reaccion mucho mas corto que bajo las condiciones de la reaccion de Heck convencionales. La reaccion de Heck modificada se puede utilizar en un metodo para la arilacion libre de fosfinas de un derivado O-alilico de eritromicina, en un metodo para preparar un derivado de O-alquenilarileritromicina, o en un metodo para preparar un derivado de 6-O-alquenilarileritromicina A protegido en 2¦- 15 4¦¦-hidroxilo.
MXPA03010939A 2001-05-30 2002-05-21 Un metodo de arilacion para la funcionalizacion de derivados de eritromicina de o-alilo. MXPA03010939A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29432601P 2001-05-30 2001-05-30
PCT/US2002/018348 WO2002096922A1 (en) 2001-05-30 2002-05-21 An arylation method for the functionalization of o-allyl erythromycin derivatives

Publications (1)

Publication Number Publication Date
MXPA03010939A true MXPA03010939A (es) 2004-02-27

Family

ID=23132927

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010939A MXPA03010939A (es) 2001-05-30 2002-05-21 Un metodo de arilacion para la funcionalizacion de derivados de eritromicina de o-alilo.

Country Status (16)

Country Link
US (1) US7071314B2 (es)
EP (1) EP1399458B1 (es)
JP (1) JP2004536075A (es)
KR (1) KR20040014537A (es)
CN (1) CN100422201C (es)
AT (1) ATE301128T1 (es)
BR (1) BR0206106A (es)
CA (1) CA2449173A1 (es)
DE (1) DE60205377T2 (es)
DK (1) DK1399458T3 (es)
ES (1) ES2246403T3 (es)
HK (1) HK1064390A1 (es)
IL (1) IL159004A0 (es)
MX (1) MXPA03010939A (es)
TW (1) TWI246515B (es)
WO (1) WO2002096922A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101309903B (zh) * 2005-11-16 2012-10-03 弗·哈夫曼-拉罗切有限公司 制备thoc的新方法
US7595300B2 (en) * 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
KR200457752Y1 (ko) * 2008-12-02 2012-01-02 다폰 일렉트로닉스 코퍼레이션 변압기 및 백라이트 장치
CN102766181A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 6-o-取代的红霉素衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896097A (ja) 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンb誘導体
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
JP2000509712A (ja) 1996-05-07 2000-08-02 アボツト・ラボラトリーズ 6―o―置換エリスロマイシン及びその製造方法
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
ZA987689B (en) * 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
US6124269A (en) 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
IL135792A0 (en) 1997-12-01 2001-05-20 Abbott Lab 6-o-alkyl derivatives of erythronolide b
US5932710A (en) 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
US6040440A (en) 1998-03-06 2000-03-21 Abbott Laboratories Hypophosphite deoxygenation reactions in the synthesis of erythromycin derivatives
ATE266036T1 (de) * 1999-03-15 2004-05-15 Abbott Lab 6-o-substitutierte makroliden mit antibakterieller wirkung
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives

Also Published As

Publication number Publication date
JP2004536075A (ja) 2004-12-02
WO2002096922A1 (en) 2002-12-05
DE60205377T2 (de) 2006-05-24
BR0206106A (pt) 2003-10-14
HK1064390A1 (en) 2005-01-28
DK1399458T3 (da) 2005-12-12
KR20040014537A (ko) 2004-02-14
ES2246403T3 (es) 2006-02-16
CN1633443A (zh) 2005-06-29
CN100422201C (zh) 2008-10-01
EP1399458A1 (en) 2004-03-24
DE60205377D1 (de) 2005-09-08
CA2449173A1 (en) 2002-12-05
EP1399458B1 (en) 2005-08-03
IL159004A0 (en) 2004-05-12
US20030125531A1 (en) 2003-07-03
US7071314B2 (en) 2006-07-04
TWI246515B (en) 2006-01-01
ATE301128T1 (de) 2005-08-15

Similar Documents

Publication Publication Date Title
IL147041A0 (en) Process for preparing 6-o-substituted erythromycin derivatives
MY112488A (en) Process for preparing 1-(2''-deoxy-2'',2''-difluoro-d- ribofuranosyl)-4-aminopyrimidin-one) hydrochloride
HK1043441A1 (en) Process and system for converting carbonaceous feedstocks into energy without green-house gas emissions.
IL147037A0 (en) Peptide acceptor ligation methods
EP1043065A4 (en) EXHAUST GAS PURIFICATION CATALYST, MANUFACTURING METHOD THEREOF AND EXHAUST GAS PURIFICATION METHOD
TR199901874T2 (xx) 3'-n-oksit,3'-n-dimetilamin, 9-oksim eritromisin A t�revleri.
ZA200109992B (en) Exhaust gas purifying catalyst.
ATE277068T1 (de) 2'-modifizierte oligonucleotide mit rns wirkung, die konformell eingeschränkt sind
ZA995562B (en) Process and reactor system for preparation of synthesis gas.
AU5445599A (en) Method for producing oxide catalyst for use in producing acrylonitrile or methacrylonitrile from propane or isobutane
IL150698A0 (en) Processes for preparing clarithromycin polymorphs
EP1223163A4 (en) PROCESS FOR PRODUCTION OF ACRYLONITRILE, CATALYST USAGE AND METHOD OF PREPARATION THEREOF
EP1095702A4 (en) METHOD AND CATALYST FOR PURIFYING EXHAUST GAS AND METHOD FOR PRODUCING THE CATALYST
IL124397A (en) One-pot process for the preparation of azithromycin
ZA964713B (en) Composition, process and apparatus for producing phosphine-containing gas.
HRP20010335B1 (en) Novel erythromycin derivatives, preparation method and use as medicines
ATE263181T1 (de) Chemische synthese von 6-o-alkyl erythromycin a
EP1264894A4 (en) REACTION SYSTEMS FOR ATP REGENERATION AND METHOD FOR THE CONTROL OF ADENIN NUCLEOTIDES, METHOD FOR THE DETECTION OF RNA AND METHOD FOR THE AMPLIFICATION OF ATP USING THEREOF
HK1064390A1 (en) An arylation method for the functionalization of o-allyl erythromycin derivatives
HUP0004687A2 (hu) IL-5 citokint inhibitáló 6-azauracil-származékok, eljárás előállításukra és alkalmazásuk
EP0749439A4 (en) NUCLEOTIDE OR NUCLEOSIDE PHOTOAFFINITY COMPOUNDS MODIFIED ANTIBODIES, METHODS OF THEIR PRODUCTION AND USE
AU2000279589A1 (en) Exhaust gas purifying catalyst compound, catalyst comprising said compound and method for preparing the compound
WO2001087807A3 (en) A cost effective method for selective methylation of erythromycin a derivatives
HUP0002258A3 (en) Process for manufacturing n-alk(en)oxy (or aryloxy)carbonyl)- isothiocyanate derivatives in the presence of n,n-dialkylarylamine catalyst
CA2292754A1 (en) Process for the preparation of a deoxyuridine derivative

Legal Events

Date Code Title Description
FG Grant or registration